KR101011775B1 - Method for the preparation of 2-H-1,2,4-Benzothiadiazine 1,1-Dioxide via Cu and 1,10-phenanthroline catalyzed intramolecular C-N cross coupling - Google Patents
Method for the preparation of 2-H-1,2,4-Benzothiadiazine 1,1-Dioxide via Cu and 1,10-phenanthroline catalyzed intramolecular C-N cross coupling Download PDFInfo
- Publication number
- KR101011775B1 KR101011775B1 KR1020080056886A KR20080056886A KR101011775B1 KR 101011775 B1 KR101011775 B1 KR 101011775B1 KR 1020080056886 A KR1020080056886 A KR 1020080056886A KR 20080056886 A KR20080056886 A KR 20080056886A KR 101011775 B1 KR101011775 B1 KR 101011775B1
- Authority
- KR
- South Korea
- Prior art keywords
- benzothiadiazine
- hydrogen
- dioxide
- formula
- mmol
- Prior art date
Links
- DGEZNRSVGBDHLK-UHFFFAOYSA-N c1cnc2c(nccc3)c3ccc2c1 Chemical compound c1cnc2c(nccc3)c3ccc2c1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 2
- BOHZJINKPVIBDK-UHFFFAOYSA-N O=S1(NC(CI)=Nc2c1cccc2)=O Chemical compound O=S1(NC(CI)=Nc2c1cccc2)=O BOHZJINKPVIBDK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
- B01J23/72—Copper
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
본 발명은 구리 촉매를 이용한 분자내 탄소-질소 교차 짝지움 반응을 통해 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드를 합성하는 방법에 관한 것이다. 보다 상세하게는 화학식(1)의 2-브로모벤젠술포닐아미딘 유도체를 구리촉매와 화학식(2)의 1,10-페난쓰롤린 하에 탄소-질소 교차 짝지움 반응에 의해 50∼100℃에서 화학식(3)으로 나타내는 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드 화합물을 만드는 것을 특징으로 한다.The present invention relates to a method for synthesizing 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide via an intramolecular carbon-nitrogen cross-pairing reaction using a copper catalyst. More specifically, the 2-bromobenzenesulfonylamidine derivative of formula (1) was reacted at 50 to 100 ° C. by a carbon-nitrogen cross-coupling reaction under a copper catalyst and 1,10-phenanthrosine of formula (2). It is characterized by making the 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide compound represented by General formula (3).
......화학식(1) Formula (1)
......화학식(2) Formula (2)
......화학식(3) Formula (3)
상기 화학식(1), 화학식(3)에서 R1은 알킬, 시클로알킬, 알케닐, 시클로알케닐, 알키닐, 아릴, 실릴 또는 질소, 산소 혹은 황 원자를 1개 이상 함유하는 헤테로아릴을 나타낸다.In formulas (1) and (3), R 1 represents alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, silyl or heteroaryl containing one or more nitrogen, oxygen or sulfur atoms.
상기 치환체 정의에서 알킬, 알케닐, 또는 알키닐은 바람직하게는 주사슬이 탄소원자 1 내지 10개를 함유하며, 시클로알케닐은 바람직하게는 탄소원자 3 내지 7개를 함유하고 환상 이중결합을 1개 이상 포함한다. 또한, 아릴은 바람직하게는 페닐 또는 나프틸을 나타내며, 질소, 산소 혹은 황원자를 1개 이상 함유하는 헤테로아릴은 바람직하게는 피리딜, 퓨라닐, 혹은 티에닐을 나타낸다. 또한 상기 화학식(1)의 주사슬이나 주고리에 아세틸, 티올, 알콕시, 에스테르, 플루오로 알킬 및 할로겐의 군으로부터 선택된 1종 이상의 추가적인 기능기를 포함할 수 있다.Alkyl, alkenyl, or alkynyl in the above substituent definition preferably contains 1 to 10 carbon atoms in the main chain, and cycloalkenyl preferably contains 3 to 7 carbon atoms and 1 cyclic double bond. Contains more than two. In addition, aryl preferably represents phenyl or naphthyl, and heteroaryl containing one or more nitrogen, oxygen or sulfur atoms preferably represents pyridyl, furanyl or thienyl. It may also include one or more additional functional groups selected from the group of acetyl, thiol, alkoxy, ester, fluoroalkyl and halogen in the main chain or ring of the formula (1).
탄소-질소 교차 짝지움 반응, 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드, 2-브로모벤젠술포닐아미딘 유도체, 구리촉매 Carbon-nitrogen cross-coupling reaction, 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide, 2-bromobenzenesulfonylamidine derivative, copper catalyst
Description
본 발명은 구리 촉매를 이용한 분자내 탄소-질소 교차 짝지움 반응을 통한 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드 화합물의 제조방법에 관한 것으로, 상세하게는 화학식(1)의 2-브로모벤젠술포닐아미딘 유도체를 구리 촉매와 화학식(2)의 1,10-페난쓰롤린과 세슘카보네이트 하에서 반응시켜 화학식(3)으로 나타내는 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드 화합물의 제조방법을 제공한다.The present invention relates to a method for preparing a 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide compound through an intramolecular carbon-nitrogen cross-coupling reaction using a copper catalyst. 2-Bromobenzenesulfonylamidine derivative of 1) was reacted under a copper catalyst with 1,10-phenanthrosine of formula (2) and cesium carbonate to form 2-hydrogen-1,2,4 represented by formula (3). Provided is a method for preparing a benzothiadiazine 1,1-dioxide compound.
......화학식(1) Formula (1)
......화학식(2) Formula (2)
......화학식(3) Formula (3)
상기 화학식(1), 화학식(3)에서 R1은 알킬, 시클로알킬, 알케닐, 시클로알케닐, 알키닐, 아릴, 실릴 또는 질소, 산소 혹은 황 원자를 1개 이상 함유하는 헤테로아릴을 나타낸다.In formulas (1) and (3), R 1 represents alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, silyl or heteroaryl containing one or more nitrogen, oxygen or sulfur atoms.
상기 치환체 정의에서 알킬, 알케닐, 또는 알키닐은 바람직하게는 주사슬이 탄소원자 1 내지 10개를 함유하며, 시클로알케닐은 바람직하게는 탄소원자 3 내지 7개를 함유하고 환상 이중결합을 1개 이상 포함한다. 또한, 아릴은 바람직하게는 페닐 또는 나프틸을 나타내며, 질소, 산소 혹은 황원자를 1개 이상 함유하는 헤테로아릴은 바람직하게는 피리딜, 퓨라닐, 혹은 티에닐을 나타낸다. 또한 상기 화학식(1)의 주사슬이나 주고리에 아세틸, 티올, 알콕시, 에스테르, 플루오로 알킬 및 할로겐의 군으로부터 선택된 1종 이상의 추가적인 기능기를 포함할 수 있다.Alkyl, alkenyl, or alkynyl in the above substituent definition preferably contains 1 to 10 carbon atoms in the main chain, and cycloalkenyl preferably contains 3 to 7 carbon atoms and 1 cyclic double bond. Contains more than two. In addition, aryl preferably represents phenyl or naphthyl, and heteroaryl containing one or more nitrogen, oxygen or sulfur atoms preferably represents pyridyl, furanyl or thienyl. It may also include one or more additional functional groups selected from the group of acetyl, thiol, alkoxy, ester, fluoroalkyl and halogen in the main chain or ring of the formula (1).
2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드 화합물은 중요하고 유용한 헤테로고리 화합물로서 항고혈압제와 항균제로 이용되어진다.((a) Topliss, J. G.; Yudis, M. D. J. Med. Chem. 1972, 15, 394-400. (b) Tait, A.; Luppi, A. Franchini, S.; Preziosi, E.; Parenti, C. Buccioni, M.; Marucci, G.; Leonardi, A.; Poggesi, E.; Brasili, L. Bioorg. Med. Chem. Lett. 2005, 15, 1185-1188.) 또한, 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드의 기질을 갖고 있는 1-부틸-3-(1,1-디옥사이도-2-수소-1,2,4-벤조티아디아진-3일)-4-하이드록시-2(1-수소)-퀴놀리논은 C형 간염 바이러스의 RNA 의존성 RNA 중합효소의 강력한 억제제로 알려져 있다. ((2) (a) Zhou, Y.; Webber, S. E.; Murphy, D. E.; Li, L.-S.; Dragovich, P. S.; Tran, C. V.; Sun, Z.; Ruebsam, F.; Shah, A. M.; Tsan, M.; Showalter, R. E.; Patel, R.; Li, B.; Zhao, Q.; Han, Q.; Hermann, T.; Kissinger, C. R.; LeBrun, L.; Sergeeva, M. V.; Kirkovsky, L. Bioorg. Med. Chem. Lett. 2008, 18, 1413-1418. (b) Tedesco, R.; Shaw, A. N.; Bambal, R.; Chai, D.; Concha, N. O.; Darcy, M. G.; Dhanak, D.; Fitch, D. M.; Gates, A.; Gerhardt, W. G.; Halegoua, D. L.; Han, chao.; Hofmann, G. A.; Johnston, V. K.; Kaura, A. C.; Liu, N.; Keenan, R. M.; Lin-Goerke, J.; Sarisky, R. T.; Wiggall, K. J.; Zimmerman, M. N.; Duffy, K. J. J. Med. Chem. 2006, 49, 971-983.)The 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide compound is an important and useful heterocyclic compound that is used as an antihypertensive and antimicrobial agent. ((A) Topliss, JG; Yudis, MD J. Med. Chem. 1972, 15 , 394-400. (B) Tait, A .; Luppi, A. Franchini, S .; Preziosi, E .; Parenti, C. Buccioni, M .; Marucci, G .; Leonardi, A .; Poggesi, E .; Brasili, L. Bioorg. Med. Chem. Lett. 2005, 15 , 1185-1188.) In addition, 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide 1-Butyl-3- (1,1-dioxido-2-hydrogen-1,2,4-benzothiadiazin-3yl) -4-hydroxy-2 (1-hydrogen) with substrate Quinolinone is known to be a potent inhibitor of RNA dependent RNA polymerase of hepatitis C virus. ((2) (a) Zhou, Y .; Webber, SE; Murphy, DE; Li, L.-S .; Dragovich, PS; Tran, CV; Sun, Z .; Ruebsam, F .; Shah, AM; Tsan, M .; Showalter, RE; Patel, R .; Li, B .; Zhao, Q .; Han, Q .; Hermann, T .; Kissinger, CR; LeBrun, L .; Sergeeva, MV; Kirkovsky, L Bioorg.Med.Chem.Lett . 2008, 18 , 1413-1418. (B) Tedesco, R .; Shaw, AN; Bambal, R .; Chai, D .; Concha, NO; Darcy, MG; Dhanak, D. ;; Fitch, DM; Gates, A .; Gerhardt, WG; Halegoua, DL; Han, chao .; Hofmann, GA; Johnston, VK; Kaura, AC; Liu, N .; Keenan, RM; Lin-Goerke, J Sarisky, RT; Wiggall, KJ; Zimmerman, MN; Duffy, KJ J. Med. Chem. 2006, 49 , 971-983.
종래 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드 화합물을 제조하는 일반적인 방법은 적절한 2-아미노벤젠술폰아마이드를 반응성이 좋은 카르복실릭 산 유도체와 반응시키는 방법과 ((a) Imai, Y.; Mochizuki, A.; Kakimoto, M. Synthesis, 1983, 851. (b) Imai, Y.; Sato, S. Takasawa, R. Ueda, M. Synthesis, 1981, 35-36.) N,N-디메틸-2-니트로벤젠술폰아마이드를 적절한 니트릴과 반응시키는 방법이 있다. (Su, W. Cai, H. Yang, B. J. Chem. Res. 2004, 87-88) 하지만, 이 방법들은 150℃의 높은 온도를 사용하거나 사마리움을 6당량 사용하는 것을 필요로 하는 단점이 있다.Conventional methods for preparing 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide compounds include reacting a suitable 2-aminobenzenesulfonamide with a highly reactive carboxylic acid derivative (( a) Imai, Y .; Mochizuki, A .; Kakimoto, M. Synthesis , 1983, 851. (b) Imai, Y .; Sato, S. Takasawa, R. Ueda, M. Synthesis , 1981, 35-36. N , N -dimethyl-2-nitrobenzenesulfonamide is reacted with a suitable nitrile. (Su, W. Cai, H. Yang, B. J. Chem. Res. 2004, 87-88) However, these methods require the use of a high temperature of 150 ° C. or the use of 6 equivalents of samarium. There is this.
본 발명은 구리 촉매를 이용한 분자내 탄소-질소 교차 짝지움 반응을 통해 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드 화합물의 제조방법에 관한 것으로 보다 상세하게는 후술하는 화학식(1)의 2-브로모벤젠술포닐아미딘 유도체를 구리촉매와 화학식(2)의 1,10-페난쓰롤린 하에 탄소-질소 교차 짝지움 반응에 의해 50∼100℃에서 화학식(3)으로 나타내는 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드 화합물의 제조방법을 제공한다.The present invention relates to a method for preparing 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide compound through an intramolecular carbon-nitrogen cross-coupling reaction using a copper catalyst, which will be described later in more detail. The 2-bromobenzenesulfonylamidine derivative of formula (1) was reacted at 50 to 100 DEG C by a carbon-nitrogen cross-coupling reaction under a copper catalyst and 1,10-phenanthrosine of formula (2). Provided is a method for producing a 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide compound.
본 발명은 의학적으로 매우 유용한 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드를 촉매량의 금속사용과 비교적 온화한 온도에서 합성하는 방법을 제공하고, 그 구조의 다양한 변화 가능성 모색을 통해 활용능력을 극대화 시키는 것이다.The present invention provides a method for synthesizing medically very useful 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide at a relatively mild temperature with the use of catalytic amounts of metal and exploring the possibility of various changes in its structure. It is to maximize the ability through.
본 발명은 후술하는 화학식(1)의 2-브로모벤젠술포닐아미딘 유도체를 구리촉매와 화학식(2)의 1,10-페난쓰롤린 하에 탄소-질소 교차 짝지움 반응에 의해 50∼100℃에서 화학식(3)으로 나타내는 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드 화합물의 제조방법을 제공한다.The present invention relates to a 2-bromobenzenesulfonylamidine derivative of formula (1) described below by a carbon-nitrogen cross-coupling reaction under a copper catalyst and 1,10-phenanthrosine of formula (2). Provided is a method for producing the 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide compound represented by the formula (3).
본 발명은 분자내 탄소-질소 교차 짝지움 반응을 통해 후술하는 화학식(3)으 로 나타내는 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드 화합물을 비교적 온화한 반응조건에서 고수율로 얻을 수 있다. The present invention provides a 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide compound represented by the following formula (3) through intramolecular carbon-nitrogen cross-coupling reaction under relatively mild reaction conditions. Obtained in yield.
본 발명은 구리 촉매를 이용한 분자내 탄소-질소 교차 짝지움 반응을 통한 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드 화합물의 제조에 있어서, 화학식(1)의 2-브로모벤젠술포닐아미딘 유도체를 구리 촉매와 화학식(2)의 1,10-페난쓰롤린과 세슘카보네이트 하에서 반응시켜 화학식(3)으로 나타내는 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드 화합물을 제조할 수 있다.The present invention provides a 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide compound through an intramolecular carbon-nitrogen cross-coupling reaction using a copper catalyst. A bromobenzenesulfonylamidine derivative is reacted under a copper catalyst with 1,10-phenanthrosine of formula (2) and cesium carbonate to form 2-hydrogen-1,2,4-benzothiadiazine represented by formula (3). 1,1-dioxide compounds can be prepared.
......화학식(1) Formula (1)
......화학식(2) Formula (2)
......화학식(3) Formula (3)
상기 화학식(1), 화학식(3)에서 R1은 알킬, 시클로알킬, 알케닐, 시클로알케닐, 알키닐, 아릴, 실릴 또는 질소, 산소 혹은 황 원자를 1개 이상 함유하는 헤테로아릴을 나타낸다.In formulas (1) and (3), R 1 represents alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, silyl or heteroaryl containing one or more nitrogen, oxygen or sulfur atoms.
상기 치환체 정의에서 알킬, 알케닐, 또는 알키닐은 바람직하게는 주사슬이 탄소원자 1 내지 10개를 함유하며, 시클로알케닐은 바람직하게는 탄소원자 3 내지 7개를 함유하고 환상 이중결합을 1개 이상 포함한다. 또한, 아릴은 바람직하게는 페닐 또는 나프틸을 나타내며, 질소, 산소 혹은 황원자를 1개 이상 함유하는 헤테로아릴은 바람직하게는 피리딜, 퓨라닐, 혹은 티에닐을 나타낸다. 또한 상기 화학식(1)의 주사슬이나 주고리에 아세틸, 티올, 알콕시, 에스테르, 플루오로 알킬 및 할로겐의 군으로부터 선택된 1종 이상의 추가적인 기능기를 포함할 수 있다.Alkyl, alkenyl, or alkynyl in the above substituent definition preferably contains 1 to 10 carbon atoms in the main chain, and cycloalkenyl preferably contains 3 to 7 carbon atoms and 1 cyclic double bond. Contains more than two. In addition, aryl preferably represents phenyl or naphthyl, and heteroaryl containing one or more nitrogen, oxygen or sulfur atoms preferably represents pyridyl, furanyl or thienyl. It may also include one or more additional functional groups selected from the group of acetyl, thiol, alkoxy, ester, fluoroalkyl and halogen in the main chain or ring of the formula (1).
본 발명의 분자내 탄소-질소 교차 짝지움 반응을 통한 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드의 제조방법은 하기 반응식(1)로 간단히 나타낼 수 있다. The preparation method of 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide through the intramolecular carbon-nitrogen cross-coupling reaction of the present invention can be simply represented by the following scheme (1).
반응식(1)Scheme (1)
상기 반응식(1)에서 화학식(1)의 2-브로모벤젠술포닐아미딘 유도체 100몰%에 대해, 화학식(2)의 1,10-페난쓰롤린(1,10-phenanthroline) 10∼30몰%, 세슘카보네이트(Cs2CO3) 150∼250몰%를 사용할 수 있다.10 to 30 moles of 1,10-phenanthroline (1,10-phenanthroline) of formula (2) relative to 100 mol% of 2-bromobenzenesulfonylamidine derivative of formula (1) in Scheme (1) %, Cesium carbonate (Cs 2 CO 3 ) 150 to 250 mol% can be used.
상기 반응식(1)에서 화학식(1)의 2-브로모벤젠술포닐아미딘 유도체 100몰%에 대해, 화학식(2)의 1,10-페난쓰롤린은 20몰%, 세슘카보네이트 200몰%를 사용할 수 있다.To 100 mol% of 2-bromobenzenesulfonylamidine derivatives of the formula (1) in the above scheme (1), 20 mol% of 1,10-phenanthrosine of the formula (2) and 200 mol% of cesium carbonate Can be used.
본 발명에서의 구리 촉매는 산화수 +1가의 구리 금속으로, 바람직하게는 음이온과 염을 이루고 있으며 화학식 (5)으로 나타낼 수 있다.The copper catalyst in the present invention is a copper metal having an oxidation number of +1, preferably a salt with an anion, and can be represented by the formula (5).
CuY......화학식(5)CuY ...... (5)
상기 화학식(5)에서 Y는 음이온으로서 할로겐이온이나 황산염, 질산염, 초산염, 또는 그 유도체를 사용할 수 있는데 구리 할로겐염을 사용하는 것이 반응 속도와 수득율 면에서 보다 바람직하고, 구리 할로겐염 중에서도 요오드화 구리를 사용하는 것이 가장 효과적이다. In the formula (5), Y may be a halogen ion, a sulfate, a nitrate, a acetate, or a derivative thereof as an anion. The use of a copper halogen salt is more preferable in terms of reaction rate and yield, and copper iodide may be It is most effective to use.
본 발명에서 구리 금속 촉매는 상기 화학식(1)의 2-브로모벤젠술포닐아미딘 유도체를 기준으로 1∼20몰%를 사용할 수 있는데, 보다 바람직하게는 5∼10몰%를 사용하는 것이 효과적이다. 실험에 의하여 확인한 촉매사용량에 따른 수득률은 1몰% 이하의 촉매사용량에 대해 감소됨을 보였고, 20몰% 이상의 촉매사용량에 대해서는 더 개선되지 않는 결과를 보였다. 그러므로 본 발명의 목적물인 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드를 효과적으로 얻기 위한 구리 촉매의 사용량은 상기 화학식(1)의 2-브로모벤젠술포닐아미딘 유도체에 대해 1∼20몰%이 가장 바람직하다.In the present invention, the copper metal catalyst may be used in an amount of 1 to 20 mol% based on the 2-bromobenzenesulfonyl amidine derivative of Formula (1), more preferably 5 to 10 mol%. to be. Yield according to the catalyst usage confirmed by the experiment was shown to decrease for less than 1 mol% catalyst usage, and showed no improvement for more than 20 mol% catalyst usage. Therefore, the amount of copper catalyst used for effectively obtaining 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide as an object of the present invention is 2-bromobenzenesulfonylamidine derivative of Formula (1). 1-20 mol% is most preferable with respect to.
본 발명에서 무기 염기로는 포타슘카보네이트, 포타슘포스페이트, 세슘카보네이트의 군으로부터 선택된 어느 하나 이상을 사용할 수 있으나, 최종 목적물의 좋은 수율을 얻기 위해 보다 바람직하게는 세슘카보네이트를 사용하는 것이 좋다.In the present invention, as the inorganic base, any one or more selected from the group consisting of potassium carbonate, potassium phosphate, and cesium carbonate may be used, but more preferably cesium carbonate is used to obtain a good yield of the final target.
본 발명에서 용매는 반응에 악영향을 주지 않는 모든 유기 용매를 사용할 수 있으며 보다 바람직하게는 디메틸포름아미드를 사용하는 것이 좋다. 용매의 양은 화학식(1)의 2-브로모벤젠술포닐아미딘유도체를 기준으로 0.01∼1.0M 농도로 바람직하게는 0.1∼0.5M 농도로 사용할 수 있는데 용매의 양이 0.01M 농도 미만으로 너무 적으면 반응 시 교반이 안될 수 있고, 1.0M 농도로 너무 많은 경우 반응이 완결되지 않거나 수득률이 낮아지는 문제가 있으므로 용매의 양은 화학식(1)의 2-브로모벤젠술포닐아미딘유도체를 기준으로 0.01∼1.0M 농도가 바람직하다. 반응 시간은 수득률이 떨어지는 문제점을 방지하기 위해서 12∼24시간 바람직하게는 16시간이 필요하고, 24시간 이상의 반응시간에 대해서는 수득률의 향상이 보이지 않았기 때문에, 보다 경제적으로 효과적인 수득률을 얻기 위해서는 12∼24시간 바람직하게는 16시간의 반응시간이 좋다. In the present invention, the solvent may be used any organic solvent that does not adversely affect the reaction, more preferably dimethylformamide. The amount of the solvent may be used at a concentration of 0.01 to 1.0 M, preferably at a concentration of 0.1 to 0.5 M, based on the 2-bromobenzenesulfonylamidine derivative of Formula (1). If the reaction may not be stirred, and if too much at 1.0M concentration, the reaction is not completed or the yield is low, so the amount of solvent is 0.01 based on 2-bromobenzenesulfonylamidine derivative of formula (1). A concentration of ˜1.0 M is preferred. The reaction time is 12 to 24 hours, preferably 16 hours in order to prevent the problem of low yield, and since the improvement of the yield was not seen for the reaction time of 24 hours or more, 12 to 24 to obtain a more economically effective yield Time Preferably, the reaction time of 16 hours is good.
본 발명에서 반응 온도는 50∼100℃, 보다 바람직 하기로는 80℃ 정도가 적절한데 온도가 50℃ 미만으로 낮을 경우에는 반응속도가 느리고, 온도가 100℃ 초과하여 높을 경우에는 여러 불필요한 반응이 수반되어 반응 온도는 50∼100℃, 보다 바람직 하기로는 80℃ 정도가 적절하다.In the present invention, the reaction temperature is 50 to 100 ℃, more preferably about 80 ℃ is suitable when the temperature is lower than 50 ℃ is a slow reaction rate, when the temperature is higher than 100 ℃ is accompanied with various unnecessary reactions Reaction temperature is 50-100 degreeC, More preferably, about 80 degreeC is suitable.
본 발명은 상기에서 언급한 방법에 의해 제조되고, 상기 화학식(3)으로 나타내는 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드 화합물을 포함한다.The present invention is prepared by the above-mentioned method and includes the 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide compound represented by the formula (3).
이하, 본 발명을 하기 실시 예에 의거하여 보다 구체적으로 설명한다. 그러나, 이들 실시 예는 본 발명에 대한 이해를 돕기 위한 것으로서 이들에 의해 본 발 명의 권리범위가 한정되는 것은 아니다Hereinafter, the present invention will be described in more detail based on the following examples. However, these examples are provided to help the understanding of the present invention, and the scope of the present invention is not limited thereto.
<실시예 1> 3-벤질-2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드Example 1 3-benzyl-2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide
10mL의 플라스크에 요오드화구리(5.7mg, 0.03mmol), 1,10-페난쓰롤린(10.8mg, 0.06mmol), 세슘카보네이트(195.5mg, 0.6mmol), N-(2-브로모벤젠술포닐)-2-페닐아세트아미딘(106.0mg, 0.3mmol)을 넣고 유기용매로 디메틸포름아미드 4mL를 첨가한 다음 반응물을 80℃에서 16시간 동안 교반하였다. 16시간 후 포화 염화나트륨 용액 4mL와 에틸아세테이트 4mL를 가한 후 유기층을 분리하였다. 물층을 에틸아세테이트 4mL로 두 번 씻어 유기층을 추출하였다. 황산마그네슘으로 탈수한 후 유기 용매를 감압 건조기로 제거하고 남은 반응 혼합물은 재결정을 통해 정제하여 엷은 노락색 고체의 3-벤질-2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드를 75%의 수율로 얻었다. Copper iodide (5.7 mg, 0.03 mmol), 1,10-phenanthrosine (10.8 mg, 0.06 mmol), cesium carbonate (195.5 mg, 0.6 mmol), N- (2-bromobenzenesulfonyl) in a 10 mL flask 2-phenylacetamidine (106.0 mg, 0.3 mmol) was added thereto, 4 mL of dimethylformamide was added as an organic solvent, and the reaction was stirred at 80 ° C. for 16 hours. After 16 hours, 4 mL of saturated sodium chloride solution and 4 mL of ethyl acetate were added thereto, and the organic layer was separated. The aqueous layer was washed twice with 4 mL of ethyl acetate and the organic layer was extracted. After dehydration with magnesium sulfate, the organic solvent was removed with a vacuum dryer, and the remaining reaction mixture was purified by recrystallization to give 3-benzyl-2-hydrogen-1,2,4-benzothiadiazine 1,1- as a pale yellow solid. Dioxide was obtained in 75% yield.
Yellowish solid; m.p. 213-214℃; 1H NMR (400 MHz, DMSO-d 6) δ 12.2 (s, 1H), 7.78(d, J = 7.5 Hz, 1H), 7.67 (t, J = 7.5 Hz, 1H), 7.45-7.28 (m, 7H), 3.87(s, 2H); 13C NMR (100 MHz, DMSO-d 6) δ 158.5, 135.1, 135.0, 133.1, 129.0, 128.6, 127.1, 126.4, 123.4, 121.1, 117.5, 41.5; IR (KBr) ν 3436, 3255, 1613, 1578, 1531, 1492, 1274, 1162, 767 cm-1 HRMS(FAB) m/z calcd. for C14H13O2N2S [M+H]+: 273.0698, found: 273.0695.Yellowish solid; mp 213-214 ° C; 1 H NMR (400 MHz, DMSO- d 6 ) δ 12.2 (s, 1H), 7.78 (d, J = 7.5 Hz, 1H), 7.67 (t, J = 7.5 Hz, 1H), 7.45-7.28 (m, 7H), 3.87 (s, 2 H); 13 C NMR (100 MHz, DMSO- d 6) δ 158.5, 135.1, 135.0, 133.1, 129.0, 128.6, 127.1, 126.4, 123.4, 121.1, 117.5, 41.5; IR (KBr) v 3436, 3255, 1613, 1578, 1531, 1492, 1274, 1162, 767 cm -1 HRMS (FAB) m / z calcd. for C 14 H 13 O 2 N 2 S [ M + H ] + : 273.0698, found: 273.0695.
<실시예 2> 3-펜틸-2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드Example 2 3-pentyl-2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide
실시예 1과 동일한 방법으로 진행하되 N-(2-브로모벤젠술포닐)-2-페닐아세트아미딘 대신 N-(2-브로모벤젠술포닐)헥산아미딘을 사용하면 흰색 고체의 3-펜틸-2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드를 86%의 수율로 얻었다.Proceed in the same manner as in Example 1, but using N- (2-bromobenzenesulfonyl) hexaneamidine instead of N- (2-bromobenzenesulfonyl) -2-phenylacetamidine 3- Pentyl-2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide was obtained in a yield of 86%.
white solid; m.p. 158-159℃; 1H NMR (400 MHz, DMSO-d 6) δ 11.9 (s, 1H), 7.77 (d, J = 7.3 Hz, 1H), 7.65 (t, J = 7.3 Hz, 1H), 7.41 (t, J = 7.6 Hz, 1H), 7.31 (d, J = 8.2 Hz, 1H), 2.52 (t, J = 7.4 Hz, 2H), 1.70-1.63 (m, 2H), 1.32-1.30 (m, 4H), 0.87 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, DMSO-d 6) δ160.3, 135.1, 133.0, 126.1, 123.4, 121.2, 117.3, 35.2, 30.4, 25.7, 21.7, 13.8 IR (NaCl) ν 3274, 3184, 3126, 1611, 1582, 1534, 1288, 1154, 1134, 759 cm-1 HRMS (EI) m/z calcd. for C12H16O2N2S [M]+: 252.0932, found: 252.0936white solid; mp 158-159 ° C .; 1 H NMR (400 MHz, DMSO- d 6 ) δ 11.9 (s, 1H), 7.77 (d, J = 7.3 Hz, 1H), 7.65 (t, J = 7.3 Hz, 1H), 7.41 (t, J = 7.6 Hz, 1H), 7.31 (d, J = 8.2 Hz, 1H), 2.52 (t, J = 7.4 Hz, 2H), 1.70-1.63 (m, 2H), 1.32-1.30 (m, 4H), 0.87 ( d, J = 6.9 Hz, 3H); 13 C NMR (100 MHz, DMSO- d 6) δ160.3, 135.1, 133.0, 126.1, 123.4, 121.2, 117.3, 35.2, 30.4, 25.7, 21.7, 13.8 IR (NaCl) ν 3274, 3184, 3126, 1611, 1582, 1534, 1288, 1154, 1134, 759 cm -1 HRMS (EI) m / z calcd. for C 12 H 16 O 2 N 2 S [ M ] + : 252.0932, found: 252.0936
<실시예 3> 3-메틸-2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드Example 3 3-methyl-2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide
실시예 1과 동일한 방법으로 진행하되 N-(2-브로모벤젠술포닐)-2-페닐아세트아미딘 대신 N-(2-브로모벤젠술포닐)-2-트리메틸실릴아세트아미딘을 사용하면 엷은 노란색 고체의 3-메틸-2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드를 72%의 수율로 얻었다.Proceed in the same manner as in Example 1, but using N- (2-bromobenzenesulfonyl) -2-trimethylsilylacetamidine instead of N- (2-bromobenzenesulfonyl) -2-phenylacetamidine A pale yellow solid, 3-methyl-2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide, was obtained in 72% yield.
yellowish solid; m.p. 254-255℃;1H NMR (400 MHz, DMSO-d 6) δ 12.0 (s, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.65 (t, J = 7.2 Hz, 1H), 7.41 (t, J = 7.5 Hz, 1H), 7.29 (d, J = 8.2 Hz, 1H), 2.29 (s, 3H); 13C NMR (100 MHz, DMSO-d 6) δ 157.1, 135.1, 133.0, 126.1, 123.4, 121.0, 117.2, 22.6 IR (KBr) ν 3446, 3265, 3184, 3124, 1614, 1585, 1534, 1479, 1277, 1159, 813, 763cm-1 HRMS (EI) m/z calcd. for C8H8O2N2S [M]+: 196.0306, found: 196.0304.yellowish solid; mp 254-255 ° C .; 1 H NMR (400 MHz, DMSO- d 6 ) δ 12.0 (s, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.65 (t, J = 7.2 Hz, 1H), 7.41 (t, J = 7.5 Hz, 1H), 7.29 (d, J = 8.2 Hz, 1H), 2.29 (s, 3H); 13 C NMR (100 MHz, DMSO- d 6) δ 157.1, 135.1, 133.0, 126.1, 123.4, 121.0, 117.2, 22.6 IR (KBr) ν 3446, 3265, 3184, 3124, 1614, 1585, 1534, 1479, 1277 , 1159, 813, 763 cm -1 HRMS (EI) m / z calcd. for C 8 H 8 O 2 N 2 S [ M ] + : 196.0306, found: 196.0304.
상술한 바와 같이, 본 발명의 바람직한 실시예를 참조하여 설명하였지만 해당 기술 분야의 숙련된 당업자라면 하기의 특허청구범위에 기재된 본 발명의 사상 및 영역으로부터 벗어나지 않는 범위 내에서 본 발명을 다양하게 수정 및 변경시킬 수 있음을 이해할 수 있을 것이다. As described above, although described with reference to a preferred embodiment of the present invention, those skilled in the art will be variously modified and modified within the scope of the present invention without departing from the spirit and scope of the invention described in the claims below. It will be appreciated that it can be changed.
본 발명은 분자내 탄소-질소 교차 짝지움 반응을 통해 상기 화학식(3)으로 나타내는 2-수소-1,2,4-벤조티아디아진 1,1-디옥사이드 화합물을 비교적 온화한 반 응조건에서 고수율로 얻을 수 있으므로 산업상 이용가능성이 있다. The present invention provides a high yield of the 2-hydrogen-1,2,4-benzothiadiazine 1,1-dioxide compound represented by the formula (3) through intramolecular carbon-nitrogen cross-coupling reaction under relatively mild reaction conditions. As it can be obtained, there is industrial applicability.
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080056886A KR101011775B1 (en) | 2008-06-17 | 2008-06-17 | Method for the preparation of 2-H-1,2,4-Benzothiadiazine 1,1-Dioxide via Cu and 1,10-phenanthroline catalyzed intramolecular C-N cross coupling |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080056886A KR101011775B1 (en) | 2008-06-17 | 2008-06-17 | Method for the preparation of 2-H-1,2,4-Benzothiadiazine 1,1-Dioxide via Cu and 1,10-phenanthroline catalyzed intramolecular C-N cross coupling |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090131097A KR20090131097A (en) | 2009-12-28 |
KR101011775B1 true KR101011775B1 (en) | 2011-02-07 |
Family
ID=41690394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080056886A KR101011775B1 (en) | 2008-06-17 | 2008-06-17 | Method for the preparation of 2-H-1,2,4-Benzothiadiazine 1,1-Dioxide via Cu and 1,10-phenanthroline catalyzed intramolecular C-N cross coupling |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101011775B1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378704A (en) | 1992-04-15 | 1995-01-03 | E. R. Squibb & Sons, Inc. | Non-peptidic angiotensin-II-receptor-antagonists |
-
2008
- 2008-06-17 KR KR1020080056886A patent/KR101011775B1/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378704A (en) | 1992-04-15 | 1995-01-03 | E. R. Squibb & Sons, Inc. | Non-peptidic angiotensin-II-receptor-antagonists |
Non-Patent Citations (1)
Title |
---|
Synthesis, Vol. 10. p. 851, 1983. |
Also Published As
Publication number | Publication date |
---|---|
KR20090131097A (en) | 2009-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101379070B1 (en) | Process for the oxidation of certain substituted sulfilimines to insecticidal sulfoximines | |
CN101641331A (en) | The method for preparing the sulfilimine of some replacement | |
JPWO2007125736A1 (en) | Method for producing methylene disulfonate compound | |
CN104262213A (en) | Method for synthesizing alpha-aryl-beta-sulfonyl amide | |
TW201209046A (en) | Method for producing a methylene disulfonate compound | |
KR101011775B1 (en) | Method for the preparation of 2-H-1,2,4-Benzothiadiazine 1,1-Dioxide via Cu and 1,10-phenanthroline catalyzed intramolecular C-N cross coupling | |
CN103130810B (en) | Synthesis method of pyrrolo[1,5-c] quinazoline compounds | |
JPH0623132B2 (en) | Method for producing alkoxysalicylic acid derivative | |
KR100499901B1 (en) | Manufacturing method of pyridylmethyl isothiocyanate | |
CN110804012B (en) | Method for reducing mercaptal or thioketone for desulfurization | |
CN110950836B (en) | Preparation method of benzodithiol heterocyclic alkene skeleton compound | |
KR20020008044A (en) | Process for preparing hydrazodicarbonamide (HDC) via ketimines | |
EP3562807B1 (en) | Processes for the preparation of pesticidal compounds | |
JP5582682B2 (en) | Method for producing substituted 4-alkoxycarbonyl-3-aminothiophenes | |
JP4345095B2 (en) | Method for highly selective O-alkylation of amide compounds using copper salts | |
KR101006737B1 (en) | Process for the preparation of 2-sulfonyliminoindoline using Cu catalyst | |
KR20180088397A (en) | Method for producing 2-alkyl-4-trifluoromethyl-3-alkylsulfonylbenzoic acid by chemical selective thioether oxidation | |
JP3950422B2 (en) | Azadirs Alder Reaction Method | |
KR100897610B1 (en) | Process for the preparation of n-phosphorylamidine using cu catalyst | |
JPH0372051B2 (en) | ||
CN115043880A (en) | Nitrogen-antimony-octylepisulfide/selenium derivative and efficient synthesis method thereof | |
CN108997252B (en) | Green synthesis method of oxadiazole derivative | |
KR100746342B1 (en) | Preparation process of n-sulfonylamide compound in existent of cu-catalyzed | |
JP6868890B2 (en) | Method for producing nitrogen-containing cyclic compound having a substituent on the ring | |
JP4853911B2 (en) | Method for producing isothiazolopyridin-3-one compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20131231 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20151229 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20161227 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180125 Year of fee payment: 8 |
|
LAPS | Lapse due to unpaid annual fee |